Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 10, 2006, Pages 1391-1398

  Hong, Xuezhi ^a   Tang, Huiqing ^b   Wu, Limao ^a   Li, Anda ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Guangxi Traditional Chinese Medicine College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALISMA ORIENTALIS EXTRACT; ASPARTATE AMINOTRANSFERASE; GLUCOSE; INSULIN; LIPID; MALONALDEHYDE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVATION; FATTY LIVER; GLUCOSE BLOOD LEVEL; HEPATOMEGALY; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; RAT;

ALANINE TRANSAMINASE; ALISMA; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; CHOLESTEROL; FASTING; FATTY LIVER; INSULIN; LIVER; LIVER FUNCTION TESTS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PLANT EXTRACTS; PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 33750067702     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.57.10.0013     Document Type: Article

References (38)

1. Adams, L. A., Angulo, P., Lindor, K. D. (2005) Nonalcoholic fatty liver disease. Can. Med. Assoc. J. 172: 899-905
2. Angulo, P., Lindor, K. D. (2001) Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin. Liver. Dis. 21: 81-88
3. Caldwell, S. H., Hespenheide, E. E., Redick, J. A., Iezzoni, J. C., Battle, E. H., Sheppard, B. L.(2001) A pilot study of a thiazolidin-edione, troglitazone, in nonalcoholic steatohepatitis. Am. J. Gastroenterol. 96: 519-525
4. Cao, Z. G., Wu, W., Liu, J. H., Wu, J. Z., Ying, C. P. (2005) Inhibition of the three constituents from Alisma orientalis on formation of urinary calcium oxalate calculus in vitro. Chin. J. New Drugs 14: 166-168
5. Chitturi, S., Abeygunasekera, S., Farrell, G. C. (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35: 373-379
6. Choudhury, J., Sanyal, A. J. (2004) Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 575-594
7. Clark, J. M., Brancati, F., Diehl, A. (2002) Nonalcoholic fatty liver disease. Gastroenterology. 122: 1649-1657
8. Clark, J. M., Brancati, F., Diehl, A. (2003) The prevalence and etiology of elevated amino transferase levels in the United States. Am. J. Gastroenterol. 98: 960-967
9. Cockell, K. A., Wotherspoon, A. T. L., Belonjea, B., Fritz, M. E. (2005) Limited effects of combined dietary copper deficiency/iron overload on oxidative stress parameters in rat liver and plasma. J. Nutr. Biochem. 16: 750-756
10. Day, C. P., James, O. F. W. (1998) Steatohepatitis: a tale of two 'hits'? Gastroenterology 114: 842-845
11. Dixon, J. B., Bhathal, P. S., Hughes, N. R., O'Brien, P. E. (2004) Non-alcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39: 1647-1654
12. Feng, Z. J, Zha, J. X., Sun, Y. F. (2003) Endothelium-dependent relaxation effect of Rhizoma Alismatis in aortic rings of liver cirrhotic rats. Clin. J. Int. Trad. West Dig. 11: 90-92
13. Gardner, H. W. (1989) Oxygen radical chemistry of polyunsaturated fatty acids. Free Radic. Biol. Med. 7: 65-86
14. Giannini, E. G., Testa, R., Savarino, V. (2005) Liver enzyme alteration: a guide for clinicians. Can. Med. Assoc. J. 172: 367-379
15. Hansen, P. A., Han, D. H., Nolte, L. A., Chen, M. (1997) DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 273: R1704-R1708
16. Jimba, S., Nakagami, T., Takahashi, M., Wakamatsu, T. (2005) Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet. Med. 22: 114-115
17. Kaplowitz N. (2005) Idiosyncratic drug hepatotoxicity. Nature Rev. 4: 489-499
18. Kumagai, T., Kawamoto, Y., Nakamura, Y. (2000) 4-Hydroxy-2-nonenal. the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem. Biophys. Res. Commun. 273: 437-441
19. Laurin, J., Lindor, K. D., Crippin, J. S. (1996) Ursodeoxycholic acid or clofibrate in the treatment of non-alcoholic-induced steatohepatitis: a pilot study. Hepatology 23: 1464-1467
20. Li, G. W., Hu, Y.H., Yang, W. Y. (1998) Effects of insulin resistance and insulin secretion on the development of type II diabetes mellitus. Chin. J. Intern. Med. 37: 600-604
21. Lieber, C. S., Leo, M. A., Mak, K. M., Xu, Y. Q. (2004) Model of nonalcoholic steatohepatitis. Am. J. Clin. Nutr. 79: 502-509
22. Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S. (2001a) Non-alcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850
23. Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Zoli, M., Melchionda, N. (2001b) Metformin in non-alcoholic steatohepatitis. Lancet 358: 893-894
24. Matteoni, C., Younossi, Z. M., McCullough, A. (1999) Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity. Gastroenterology 116: 1413-1419
25. Neuschwander-tetri, B. A. (2005) Nonalcoholic steatohepatitis and the metabolic syndrome. Am. J. Med. Sci. 330: 326-335
26. Paradis, V., Perlemuter, G., Bonvoust, F., Dargere, D. (2001) High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 34: 738-744
27. Peng, G. P., Lou, F. C., Feng, X. (2002) Structure of orientanone from Alisma orientalis, a novel sesquiterpene originating from guaiane type carbon skeleton by isopropyl shift. Tetrahedron 58: 9045-9048
28. Polavarapu, R., Spitz, D. R., Sim, J. E., Follansbee, M. H. (1998) Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 27: 1317-1323
29. Robertson, G., Leclercq, I., Farrell, G. C. (2001) Nonalcoholic steatosis and steatohepatitis: II. Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1135-G1139
30. Samuel, V. T., Liu, Z. X., Qu, X. Q. (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279: 32345-32353
31. Seki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., Wakasa, K. (2002) In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J. Hepatol. 37: 56-62
32. Sunithan, P. T., Nagaraj, M., Varalakshmi, P. (2001) Hepatoprotective effect of lupeol and lupeol linoleate on tissue antioxidant defence system in cadmium-induced hepatotoxicity in rats. Fitoterapia 72: 516-523
33. Wang, L. X., Wu, Q. N., Peng, G. P. (2002) A study on determination of content of 23-acetyl alisol B in Rhizma Alisma Orientalis. J. Nanjing TCM Univer.-Natu. Sci. 18: 105-108
34. Wang, Q. E., Qiu, Z. C., Jin, B. H., Wang, X. R. (2003) Rapid determination of triterpenoid alcohol ketones in Alisma orientalis. J. Xiamen Univer.-Natu. Sci. 42: 751-755
35. Yang, X. B., Huang, Z. M. (1998) Effects of rhizome alismatis extract on blood glucose in normal and diabetes. Pharmacol. Clin. Chin. Mater. Medica 14: 29-30
36. Yang, X. B., Huang, Z. M., Cao, W. B., Chen, W. (2004) Effects of rhizome alismatis extract on blood biochemical induces and insulin in hyperglycemic mice. Chin. J. Clin. Rehab. 8: 1196-1197
37. Yin, C. P., Wu, J. Z. (2001) Advances in studies on immunoregulation of Alisma orientalis and its active constituents. Chin. Trad. Herbal Drugs 32: 1132-1133
38. Zeng, M. D. (2003) Stress on research of nonalcoholic fatty liver disease. Chin. J. Hepatol. 11: 69-70